J 2021

COVID-19 Vaccines Safety Tracking (CoVaST): Protocol of a Multi-Center Prospective Cohort Study for Active Surveillance of COVID-19 Vaccines’ Side Effects

RIAD, Abanoub, Holger SCHÜNEMANN, Sameh ATTIA, Tina POKLEPOVIĆ PERIČIĆ, Marija Franka ŽULJEVIĆ et. al.

Basic information

Original name

COVID-19 Vaccines Safety Tracking (CoVaST): Protocol of a Multi-Center Prospective Cohort Study for Active Surveillance of COVID-19 Vaccines’ Side Effects

Authors

RIAD, Abanoub (818 Egypt, guarantor, belonging to the institution), Holger SCHÜNEMANN, Sameh ATTIA, Tina POKLEPOVIĆ PERIČIĆ, Marija Franka ŽULJEVIĆ, Mikk JÜRISSON, Ruth KALDA, Katrin LANG, Sudhakar MORANKAR, Elias Ali YESUF, Mohamed MEKHEMAR, Anthony DANSO-APPIAH, Ahmad SOFI-MAHMUDI, Giordano PÉREZ-GAXIOLA, Arkadiusz DZIEDZIC, João APÓSTOLO, Daniela CARDOSO, Janja MARC, Mayte MORENO-CASBAS, Charles Shey WIYSONGE, Amir QASEEM, Anna GRYSCHEK, Ivana TADIĆ, Mohammad Salman HUSSAIN (356 India, belonging to the institution), Mohammed Ahmed KHAN, Jitka KLUGAROVÁ (203 Czech Republic, belonging to the institution), Andrea POKORNÁ (203 Czech Republic, belonging to the institution), Michal KOŠČÍK (203 Czech Republic, belonging to the institution) and Miloslav KLUGAR (203 Czech Republic, belonging to the institution)

Edition

International Journal of Environmental Research and Public Health, Basel, MDPI, 2021, 1660-4601

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30304 Public and environmental health

Country of publisher

Switzerland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 4.614

RIV identification code

RIV/00216224:14110/21:00122061

Organization unit

Faculty of Medicine

UT WoS

000681945000001

Keywords in English

cohort studies; cross-sectional studies; COVID-19; drug-related side effects and adverse reactions; health personnel; mass vaccination; prevalence

Tags

International impact, Reviewed
Změněno: 12/12/2022 13:40, Mgr. Tereza Miškechová

Abstract

V originále

Background: Coronavirus disease (COVID-19) vaccine-related side effects have a determinant role in the public decision regarding vaccination. Therefore, this study has been designed to actively monitor the safety and effectiveness of COVID-19 vaccines globally. Methods: A multi-country, three-phase study including a cross-sectional survey to test for the short-term side effects of COVID-19 vaccines among target population groups. In the second phase, we will monitor the booster doses’ side effects, while in the third phase, the long-term safety and effectiveness will be investigated. A validated, self-administered questionnaire will be used to collect data from the target population; Results: The study protocol has been registered at ClinicalTrials.gov, with the identifier NCT04834869. Conclusions: CoVaST is the first independent study aiming to monitor the side effects of COVID-19 vaccines following booster doses, and the long-term safety and effectiveness of said vaccines.

Links

MUNI/A/1608/2020, interní kód MU
Name: Prohlubování znalostí v oblasti zdravotních rizik a benefitů výživy, prostředí a životního stylu III
Investor: Masaryk University
MUNI/IGA/1543/2020, interní kód MU
Name: Evidence-based Practice of Healthcare Professionals and Students in the Czech Republic (Acronym: Evidence-Based Practice in Czechia)
Investor: Masaryk University